Vascular Risk Factors and Diabetic Neuropathy

Publisher Website
Google Scholar
Abstract
In the article by Tesfaye et al. (Jan. 27 issue)1 on the European Diabetes (EURODIAB) Prospective Complications Study, which looked at modifiable risk factors for diabetic neuropathy, the first line of the abstract states, “Other than glycemic control, there are no treatments for diabetic neuropathy.” Although there have been no prospective, randomized trials to date, there is a growing literature regarding the role of nerve decompression in carefully selected patients with diabetic distal, large-fiber, symmetric polyneuropathy.